NUAK2 amplification coupled with PTEN deficiency promote melanoma development via CDK activation

The AMPK-related kinase NUAK2 has been implicated in melanoma growth and survival outcomes but its therapeutic utility has yet to be confirmed. In this study, we show how its genetic amplication in PTEN-deficient melanomas may rationalize the use of CDK2 inhibitors as a therapeutic strategy. Analysi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Res
Päätekijät: Namiki, Takeshi, Yaguchi, Tomonori, Nakamura, Kenta, Valencia, Julio C., Coelho, Sergio G., Yin, Lanlan, Kawaguchi, Masakazu, Vieira, Wilfred D., Kaneko, Yasuhiko, Tanemura, Atsushi, Katayama, Ichiro, Yokozeki, Hiroo, Kawakami, Yutaka, Hearing, Vincent J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4490056/
https://ncbi.nlm.nih.gov/pubmed/25832654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-3209
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia